2022
DOI: 10.1007/s00228-021-03271-1
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of two European risk models for predicting medication harm in an Australian patient cohort

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…Anticoagulant drugs pose several risks to patients, particularly the risk of severe bleeding. The healthcare professional responsible for monitoring individuals using such medications plays a critical role in identifying signs or symptoms of ADR, monitoring changes in the INR, and providing guidance to patients and their families regarding the proper use and care (Leal et al, 2020;Falconer et al, 2022).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Anticoagulant drugs pose several risks to patients, particularly the risk of severe bleeding. The healthcare professional responsible for monitoring individuals using such medications plays a critical role in identifying signs or symptoms of ADR, monitoring changes in the INR, and providing guidance to patients and their families regarding the proper use and care (Leal et al, 2020;Falconer et al, 2022).…”
Section: Discussionmentioning
confidence: 99%
“…These tools have the potential to list individuals according to health risks, prioritizing care and targeted interventions in a hospital setting (Falconer et al, 2022). Thus, the use of risk scores that prioritize pharmaceutical interventions based on the criticality of patients becomes a necessary strategy.…”
Section: Introductionmentioning
confidence: 99%